Marshall Wace
PLSE icon

Marshall Wace’s Pulse Biosciences PLSE Stock Holding History

Marshall Wace’s Portfolio PLSE Stock Details PLSE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-13,500
Closed -$118K – 2864
2024
Q1 		$118K Sell
13,500
-13,032
-49% -$120K ﹤0.01% 2293
2023
Q4 		$325K Buy
+26,532
New +$184K ﹤0.01% 1862
2022
Q2 		– Sell
-25,575
Closed -$124K – 3751
2022
Q1 		$124K Buy
+25,575
New +$209K ﹤0.01% 3173
2019
Q1 		– Sell
-6,145
Closed -$70K – 1990
2018
Q4 		$70K Buy
+6,145
New +$74.3K ﹤0.01% 1409

Other funds holding PLSE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GAM
Griffin Asset Management New York $949M AUM 24.98% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Marshall Wace's PLSE Position: Q2 2024 in Review

Marshall Wace sold out of Pulse Biosciences (PLSE) in Q2 2024, closing a stake of 13,500 shares — an estimated $118K sold.

Marshall Wace first reported a position in PLSE in Q4 2018 and held it in 4 quarters. The position peaked at $325K in Q4 2023. 57 funds tracked by Wall St. Rank hold PLSE as of Q2 2024.

  • Marshall Wace reported no remaining Pulse Biosciences position as of Q2 2024 after selling out during the quarter.
  • Marshall Wace sold 13,500 Pulse Biosciences shares in Q2 2024, an estimated $118K.
  • Marshall Wace first reported a position in Pulse Biosciences in Q4 2018 and held it in 4 quarters.
  • Marshall Wace's Pulse Biosciences position peaked at $325K in Q4 2023.
  • 57 funds tracked by Wall St. Rank held Pulse Biosciences as of Q2 2024.

Based on Marshall Wace's 13F filing for Q2 2024, filed 14 Aug 2024.